Information Provided By: 
Fly News Breaks for August 20, 2018
IQV
Aug 20, 2018 | 08:21 EDT
Stifel analyst Shlomo Rosenbaum believes "it is just [a] matter of time before" Iqvia's growth rate inflects given the bookings strength in the Quintiles CRO business, which he notes has a long cycle where bookings precede revenue by a period of time. He believes the company's merger strategy to utilize its comprehensive data to develop a differentiated CRO product is in the early stages of playing out and that investors should buy ahead of that continuing to be evidenced. He maintains a Buy rating and $150 price target on Iqvia shares.
News For IQV From the Last 2 Days
There are no results for your query IQV
